Breaking News Instant updates and real-time market news.

POAHY

Porsche

$0.00

(0.00%)

13:17
12/03/19
12/03
13:17
12/03/19
13:17

Porsche reports November U.S. sales up 11.5% to 6,326 vehicles

Porsche Cars North America announced November retail sales rose 11.5% from a year ago to 6,326 vehicles. For the first 11 months of 2019, total retail deliveries were up 7% from a year ago to 56,835.

POAHY Porsche
$0.00

(0.00%)

04/01/19
ADAM
04/01/19
NO CHANGE
Target $450
ADAM
Buy
Tesla's Model 3 performs like a 911, priced like a 3 series, says Canaccord
After hosting a factory tour and test drive for clients at Tesla's (TSLA) Fremont facility, Canaccord Genuity analyst Jed Dorsheimer maintains a Buy rating on Tesla shares with a $450 price target. The stock in morning trading is up 1%, or $2.56, to $282.42. The analyst came away with renewed confidence in his thesis that the company maintains an advantage in the race to disrupt the internal combustion engine auto. The new $39,000 Model 3 is a "quantum leap forward in performance" and will capture the "lion-share" of current electric vehicle offerings, Dorsheimer tells investors in a research note. With the performance of a Porsche (POAHY) 911 and the price of an Audi A4 or BMW (BMWYY) 3 series, the Model 3 is the "best value proposition currently on the market today," contends Dorsheimer. And it is clear to the analyst that Tesla has built the facility for scale well beyond current volumes. Further, he was pleased to confirm that the most critical component in the electric vehicle remains the inverter, which he noes has transitioned to silicon carbide and is required with each motor. He sees this as a positive for Buy-thesis on Cree (CREE).
10/10/19
GSCO
10/10/19
INITIATION
GSCO
Buy
Porsche initiated with a Buy rating at Goldman Sachs
Goldman Sachs analyst George Galliers started Porsche with a Buy rating and 77 euros price target. The analyst sees 30% upside in the shares and a "steady path" of earnings growth in the company years.

TODAY'S FREE FLY STORIES

CORV

Correvio

$1.39

(0.00%)

14:22
12/10/19
12/10
14:22
12/10/19
14:22
Periodicals
FDA panel said to vote against recommending approval for Correvio's Brinavess »

SAC Tracker, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

14:20
12/10/19
12/10
14:20
12/10/19
14:20
General news
The Europe Brief: »

The Europe Brief:…

EVH

Evolent Health

$9.02

1.125 (14.25%)

14:17
12/10/19
12/10
14:17
12/10/19
14:17
Recommendations
Evolent Health analyst commentary  »

William Blair says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/10/19
12/10
14:17
12/10/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/10/19
12/10
14:16
12/10/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$14.09

-6.42 (-31.30%)

14:03
12/10/19
12/10
14:03
12/10/19
14:03
Downgrade
Conn's rating change  »

Conn's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

CONN

Conn's

$14.08

-6.43 (-31.35%)

13:59
12/10/19
12/10
13:59
12/10/19
13:59
Downgrade
Conn's rating change  »

Conn's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

EVH

Evolent Health

$8.46

0.565 (7.16%)

13:59
12/10/19
12/10
13:59
12/10/19
13:59
Periodicals
Kentucky committee rejects outgoing governor's 'snub' of Evolent, LBF says »

The Government Contract…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$47.78

-0.11 (-0.23%)

13:56
12/10/19
12/10
13:56
12/10/19
13:56
Conference/Events
UDR, Inc. management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

XOM

Exxon Mobil

$68.73

-0.93 (-1.34%)

13:54
12/10/19
12/10
13:54
12/10/19
13:54
Hot Stocks
Exxon: Ruling affirms position company has held throughout 'baseless' probe »

ExxonMobil issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ADPT

Adaptive Biotechnologies

$29.09

-0.21 (-0.72%)

13:54
12/10/19
12/10
13:54
12/10/19
13:54
Conference/Events
Adaptive Biotechnologies management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVGO

Livongo Health

$25.83

-1.57 (-5.73%)

13:52
12/10/19
12/10
13:52
12/10/19
13:52
Recommendations
Livongo Health analyst commentary  »

Livongo Health valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

WDFC

WD-40

$194.62

-1.12 (-0.57%)

13:51
12/10/19
12/10
13:51
12/10/19
13:51
Hot Stocks
WD-40 increases quarterly dividend nearly 10% »

WD-40 Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

13:50
12/10/19
12/10
13:50
12/10/19
13:50
General news
Treasury Action: the Treasury market is unmoved »

Treasury Action: the…

13:49
12/10/19
12/10
13:49
12/10/19
13:49
Conference/Events
JPMorgan consumer finance analyst to hold analyst/industry conference call »

Specialty & Consumer…

EVH

Evolent Health

$8.27

0.375 (4.75%)

13:49
12/10/19
12/10
13:49
12/10/19
13:49
Hot Stocks
Evolent Health jumps $1.55, or 20%, to $9.42 »

Contacts tell The Fly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
12/10/19
12/10
13:45
12/10/19
13:45
Conference/Events
JPMorgan semiconductors anayst to hold an analyst/industry conference call »

Semiconductors,…

NFLX

Netflix

$297.38

-5.1 (-1.69%)

13:45
12/10/19
12/10
13:45
12/10/19
13:45
Hot Stocks
Netflix says 'really proud' of animation work, cadence of films picking up »

Speaking at the UBS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

13:41
12/10/19
12/10
13:41
12/10/19
13:41
Conference/Events
JPMorgan restaurants analyst to hold an analyst/industry conference call »

Restaurants Analyst…

VALE

Vale

$12.35

-0.035 (-0.28%)

13:33
12/10/19
12/10
13:33
12/10/19
13:33
Conference/Events
Morgan Stanley materials analyst holds an analyst/industry conference call »

Head of Australia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$14.24

0.075 (0.53%)

13:33
12/10/19
12/10
13:33
12/10/19
13:33
Hot Stocks
CenturyLink pays Washington $6.1M to settle hidden fees lawsuit »

Washington Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CI

Cigna

$190.30

-5.59 (-2.85%)

, MET

MetLife

$49.25

-0.315 (-0.64%)

13:31
12/10/19
12/10
13:31
12/10/19
13:31
Periodicals
New York Life in talks to buy nonmedical insurance unit from Cigna, WSJ reports »

New York Life Insurance…

CI

Cigna

$190.30

-5.59 (-2.85%)

MET

MetLife

$49.25

-0.315 (-0.64%)

SLF

Sun Life Financial

$44.95

0.465 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Feb

  • 13

    Feb

UPWK

Upwork

$10.60

-0.55 (-4.93%)

13:25
12/10/19
12/10
13:25
12/10/19
13:25
Options
Upwork call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

VIAC

ViacomCBS

$38.13

-0.52 (-1.35%)

, VIACA

ViacomCBS

$41.51

-0.27 (-0.65%)

13:23
12/10/19
12/10
13:23
12/10/19
13:23
Periodicals
ViacomCBS, Paramount resume talks to buy Miramax stake, Variety reports »

ViacomCBS and Paramount…

VIAC

ViacomCBS

$38.13

-0.52 (-1.35%)

VIACA

ViacomCBS

$41.51

-0.27 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/10/19
12/10
13:17
12/10/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.